Prostate Cancer Medicine Market Report

Global and Region Prostate Cancer Medicine Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 01, 2022
  • PAGES：212
  • REPORT CODE：GMM968941
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Prostate Cancer Medicine market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Prostate Cancer Medicinemarket, defines the market attractiveness level of Prostate Cancer Medicine market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Prostate Cancer Medicine industry, describes the types of Prostate Cancer Medicine market, the applications of major players and the market size, and deeply analyzes the current situation of the global Prostate Cancer Medicine market and the development prospects and opportunities of Prostate Cancer Medicine industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Prostate Cancer Medicine market in Chapter 13.

    By Player:

    • Astellas Pharma Inc

    • Roche Holding AG

    • Johnson & Johnson

    • Bayer AG

    • Bristol Myers-Squibb

    • AstraZeneca plc

    • Active Biotech

    • Teva Pharmaceuticals Industries Ltd

    • Abbott Laboratories

    • Pfizer Inc

    By Type:

    • LHRH Antagonists

    • LHRH Analogs

    • Antiandrogens

    • Pipeline Drugs for Hormonal Therapy

    By End-User:

    • Hospitals

    • Clinics

    • Other

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Prostate Cancer Medicine Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Prostate Cancer Medicine Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Prostate Cancer Medicine Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Prostate Cancer Medicine Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Prostate Cancer Medicine Market Analysis and Outlook to 2022

    • 7.1 Global Prostate Cancer Medicine Consumption (2017-2022)

    • 7.2 United States Prostate Cancer Medicine Consumption (2017-2022)

    • 7.3 Europe Prostate Cancer Medicine Consumption (2017-2022)

    • 7.4 China Prostate Cancer Medicine Consumption (2017-2022)

    • 7.5 Japan Prostate Cancer Medicine Consumption (2017-2022)

    • 7.6 India Prostate Cancer Medicine Consumption (2017-2022)

    • 7.7 South Korea Prostate Cancer Medicine Consumption (2017-2022)

    8 Region and Country-wise Prostate Cancer Medicine Market Analysis and Outlook to 2028

    • 8.1 Global Prostate Cancer Medicine Consumption Forecast (2022-2028)

    • 8.2 United States Prostate Cancer Medicine Consumption Forecast (2022-2028)

    • 8.3 Europe Prostate Cancer Medicine Consumption Forecast (2022-2028)

    • 8.4 China Prostate Cancer Medicine Consumption Forecast (2022-2028)

    • 8.5 Japan Prostate Cancer Medicine Consumption Forecast (2022-2028)

    • 8.6 India Prostate Cancer Medicine Consumption Forecast (2022-2028)

    • 8.7 South Korea Prostate Cancer Medicine Consumption Forecast (2022-2028)

    9 Global Prostate Cancer Medicine Market Outlook by Types and Applications to 2022

    • 9.1 Global Prostate Cancer Medicine Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global LHRH Antagonists Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global LHRH Analogs Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Antiandrogens Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Pipeline Drugs for Hormonal Therapy Consumption and Growth Rate (2017-2022)

    • 9.2 Global Prostate Cancer Medicine Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Clinics Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Other Consumption and Growth Rate (2017-2022)

    10 Global Prostate Cancer Medicine Market Outlook by Types and Applications to 2028

    • 10.1 Global Prostate Cancer Medicine Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global LHRH Antagonists Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global LHRH Analogs Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Antiandrogens Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Pipeline Drugs for Hormonal Therapy Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Prostate Cancer Medicine Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Clinics Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Other Consumption Forecast and Growth Rate (2022-2028)

    11 Global Prostate Cancer Medicine Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Prostate Cancer Medicine Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Prostate Cancer Medicine Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Prostate Cancer Medicine Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Prostate Cancer Medicine Market Competitive Analysis

    • 14.1 Astellas Pharma Inc

      • 14.1.1 Astellas Pharma Inc Company Details

      • 14.1.2 Astellas Pharma Inc Prostate Cancer Medicine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Astellas Pharma Inc Prostate Cancer Medicine Product and Service

    • 14.2 Roche Holding AG

      • 14.2.1 Roche Holding AG Company Details

      • 14.2.2 Roche Holding AG Prostate Cancer Medicine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Roche Holding AG Prostate Cancer Medicine Product and Service

    • 14.3 Johnson & Johnson

      • 14.3.1 Johnson & Johnson Company Details

      • 14.3.2 Johnson & Johnson Prostate Cancer Medicine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Johnson & Johnson Prostate Cancer Medicine Product and Service

    • 14.4 Bayer AG

      • 14.4.1 Bayer AG Company Details

      • 14.4.2 Bayer AG Prostate Cancer Medicine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Bayer AG Prostate Cancer Medicine Product and Service

    • 14.5 Bristol Myers-Squibb

      • 14.5.1 Bristol Myers-Squibb Company Details

      • 14.5.2 Bristol Myers-Squibb Prostate Cancer Medicine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Bristol Myers-Squibb Prostate Cancer Medicine Product and Service

    • 14.6 AstraZeneca plc

      • 14.6.1 AstraZeneca plc Company Details

      • 14.6.2 AstraZeneca plc Prostate Cancer Medicine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 AstraZeneca plc Prostate Cancer Medicine Product and Service

    • 14.7 Active Biotech

      • 14.7.1 Active Biotech Company Details

      • 14.7.2 Active Biotech Prostate Cancer Medicine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Active Biotech Prostate Cancer Medicine Product and Service

    • 14.8 Teva Pharmaceuticals Industries Ltd

      • 14.8.1 Teva Pharmaceuticals Industries Ltd Company Details

      • 14.8.2 Teva Pharmaceuticals Industries Ltd Prostate Cancer Medicine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Teva Pharmaceuticals Industries Ltd Prostate Cancer Medicine Product and Service

    • 14.9 Abbott Laboratories

      • 14.9.1 Abbott Laboratories Company Details

      • 14.9.2 Abbott Laboratories Prostate Cancer Medicine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Abbott Laboratories Prostate Cancer Medicine Product and Service

    • 14.10 Pfizer Inc

      • 14.10.1 Pfizer Inc Company Details

      • 14.10.2 Pfizer Inc Prostate Cancer Medicine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Pfizer Inc Prostate Cancer Medicine Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Prostate Cancer Medicine

    • Figure Prostate Cancer Medicine Picture

    • Table Global Prostate Cancer Medicine Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Prostate Cancer Medicine Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Prostate Cancer Medicine Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Prostate Cancer Medicine Consumption by Country (2017-2022)

    • Figure United States Prostate Cancer Medicine Consumption and Growth Rate (2017-2022)

    • Table Europe Prostate Cancer Medicine Consumption and Growth Rate (2017-2022)

    • Figure China Prostate Cancer Medicine Consumption and Growth Rate (2017-2022)

    • Figure Japan Prostate Cancer Medicine Consumption and Growth Rate (2017-2022)

    • Figure India Prostate Cancer Medicine Consumption and Growth Rate (2017-2022)

    • Figure South Korea Prostate Cancer Medicine Consumption and Growth Rate (2017-2022)

    • Figure Global Prostate Cancer Medicine Consumption Forecast by Country (2022-2028)

    • Figure United States Prostate Cancer Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Prostate Cancer Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Prostate Cancer Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Prostate Cancer Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Prostate Cancer Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Prostate Cancer Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global LHRH Antagonists Consumption and Growth Rate (2017-2022)

    • Figure Global LHRH Analogs Consumption and Growth Rate (2017-2022)

    • Figure Global Antiandrogens Consumption and Growth Rate (2017-2022)

    • Figure Global Pipeline Drugs for Hormonal Therapy Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals Consumption and Growth Rate (2017-2022)

    • Figure Global Clinics Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global LHRH Antagonists Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global LHRH Analogs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Antiandrogens Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Pipeline Drugs for Hormonal Therapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Prostate Cancer Medicine Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Prostate Cancer Medicine Export by Region (Top 5 Countries) (2017-2028)

    • Table Astellas Pharma Inc (Foundation Year, Company Profile and etc.)

    • Table Astellas Pharma Inc Prostate Cancer Medicine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Astellas Pharma Inc Prostate Cancer Medicine Product and Service

    • Table Roche Holding AG (Foundation Year, Company Profile and etc.)

    • Table Roche Holding AG Prostate Cancer Medicine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Roche Holding AG Prostate Cancer Medicine Product and Service

    • Table Johnson & Johnson (Foundation Year, Company Profile and etc.)

    • Table Johnson & Johnson Prostate Cancer Medicine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson & Johnson Prostate Cancer Medicine Product and Service

    • Table Bayer AG (Foundation Year, Company Profile and etc.)

    • Table Bayer AG Prostate Cancer Medicine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bayer AG Prostate Cancer Medicine Product and Service

    • Table Bristol Myers-Squibb (Foundation Year, Company Profile and etc.)

    • Table Bristol Myers-Squibb Prostate Cancer Medicine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bristol Myers-Squibb Prostate Cancer Medicine Product and Service

    • Table AstraZeneca plc (Foundation Year, Company Profile and etc.)

    • Table AstraZeneca plc Prostate Cancer Medicine Sales, Price, Value and Gross Profit (2017-2022)

    • Table AstraZeneca plc Prostate Cancer Medicine Product and Service

    • Table Active Biotech (Foundation Year, Company Profile and etc.)

    • Table Active Biotech Prostate Cancer Medicine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Active Biotech Prostate Cancer Medicine Product and Service

    • Table Teva Pharmaceuticals Industries Ltd (Foundation Year, Company Profile and etc.)

    • Table Teva Pharmaceuticals Industries Ltd Prostate Cancer Medicine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Teva Pharmaceuticals Industries Ltd Prostate Cancer Medicine Product and Service

    • Table Abbott Laboratories (Foundation Year, Company Profile and etc.)

    • Table Abbott Laboratories Prostate Cancer Medicine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Abbott Laboratories Prostate Cancer Medicine Product and Service

    • Table Pfizer Inc (Foundation Year, Company Profile and etc.)

    • Table Pfizer Inc Prostate Cancer Medicine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Inc Prostate Cancer Medicine Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US